Gradient Biomodeling Announces Collaboration Agreement to Advance Discovery of New Antivirals for Neglected Tropical Diseases
PARK CITY, UT / ACCESSWIRE / October 24, 2023 / Gradient Biomodeling LLC, a pioneer in the use of quantum biomodeling and machine learning as a deep-knowledge computational platform for molecular interactions and pathways, today announced a collaboration agreement with Janssen Pharmaceutica NV, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, to advance the discovery of new treatments for neglected diseases.Billions of people...
Read more








